Skip to content
Search AI Powered
Human content, AI powered search.

Latest Stories

Reuben McDaniel Resigns from New York's Cannabis Control Board Amid Conflict of Interest Controversy

DASNY president Reuben McDaniel resigns from Cannabis Control Board
DASNY president Reuben McDaniel resigns from Cannabis Control Board
Credit: JOHNNY CRAWFORD / JCRAWFORD@AJC.COM
Harrison Wise
By Harrison WiseJun 15, 2023
Harrison Wise
Founder, Publisher and Contributing Editor at The Bluntness, Inc. Harrison is also the founder and CEO of Wise Collective, an award-winning integrated marketing communications agency that works across the Cannabis, Tech, Sports, Media and Entertainment industries. Harrison has been involved in the Cannabis industry since 2015 when he and his agency launched MedMen. They have since worked with and counseled countless businesses and brands in the cannabis industry, including but not limited to Stiiizy, Shryne Group, Cloudponics, MCR Labs, Chil, Hemptown USA, Happy Valley MA and Greatest Hits Cannabis Co. among others. For more information visit: www.wisecollective.co.
See Full Bio
Follow:

Reuben McDaniel, a member of the New York Cannabis Control Board (CCB), has stepped down from his position following mounting criticism over allegations of a conflict of interest. McDaniel, who also serves as the president of the Dormitory Authority of the State of New York (DASNY), tendered his resignation during Thursday's CCB meeting.

During the meeting, McDaniel expressed his gratitude for the opportunity to serve on the board and commended Governor Kathy Hochul's vision for advancing cannabis social equity in the state. However, he did not disclose the specific reasons for his departure. CCB Chairwoman Tremaine Wright thanked McDaniel for his service and expressed the board's continued collaboration on the social equity fund.

Former Governor Andrew Cuomo had recommended McDaniel for the presidency of DASNY in 2019, and Governor Hochul appointed him to the five-member CCB in September 2021. However, concerns regarding McDaniel's dual roles have been raised by industry stakeholders. DASNY plays a crucial role in the marketplace rollout, while the Office of Cannabis Management (OCM), which McDaniel oversaw as a CCB board member, has a distinct focus on equity.

The OCM, in its early stages, had developed the Conditional Adult-Use Retail Dispensary (CAURD) program from within DASNY's offices, leading to DASNY's significant involvement in launching the program. This involvement included securing real estate for retailers, finding a fund manager to raise $150 million, and identifying a financial institution for banking services. However, as challenges arose within the CAURD program, such as difficulties in securing real estate and insufficient funding, criticism was directed at DASNY and McDaniel.

Industry stakeholders, including the Cannabis Association of New York, have questioned the potential conflict of interest arising from McDaniel's simultaneous positions. Licensed retailers, in particular, have called for transparency and accountability from DASNY. Some CAURD applicants have accused DASNY of pressuring them into overpriced dispensary locations and providing inflated contractor bids without disclosing loan terms.

Despite his resignation from the CCB, McDaniel will continue to serve as DASNY's president, and the organization will maintain its role in developing New York's cannabis marketplace.

The Latest

macro image of trainwreck cannabis strain
Wellness

Trainwreck: Creative Daytime Lift

image of friends holding drinks with alcohol, clinking glasses to cheers
Editorial

Americans drink less, redefine going out

protesters holding sign, peaceful, democracy
News

Hemp Ban Threatens $28B Industry

Giphy of Rodney Dangerfield stretching and experiencing back-pain, in an exaggerated/funny manner
Wellness

CBD & THC for Athletes

More For You

OCM Alleges 'Rent-a-License' Scheme, Seeks License Revocation
OCM Alleges 'Rent-a-License' Scheme, Seeks License Revocation
Photo by Jon Tyson on Unsplash

NY Revokes License in Rent-a-License Scam

At-a-Glance

  • What’s new: NY’s Office of Cannabis Management (OCM) issued a Notice of Pleading (NOP) charging Omnium Health (d/b/a Omnium Canna) with facilitating unlicensed production under its license and ordered a statewide retail recall tied to products made by unlicensed processors.
  • Why it matters: Regulators call it “reverse licensing” - unlicensed operators allegedly producing/packaging cannabis under a licensee’s umbrella, which undermines market integrity and fairness.
  • Penalties sought: License revocation (processor + distributor), debarment from future licensure, civil penalties tied to projected revenue, and destruction of unlawfully made products.
  • Timeline: Investigation began February 2025; OCM announcement issued October 20, 2025; coverage followed October 22, 2025.

What Exactly Is OCM Alleging?

OCM says Omnium let unlicensed businesses use its facilities and resources, and charged them rent, creating a “rent-a-license” (aka “reverse licensing”) arrangement. Investigators cite contracts, audits, and witness testimony supporting the claim.

The NOP also points to seized materials, including unlabeled THCA isolate (no batch IDs or traceability) and packaging labeled “Omnium d/b/a MFused,” which investigators say reflected space and license rental.

Keep ReadingShow less
Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
gif of actor Kevin James from King of Queens; asking "How Much Does That Cost?"
Why Is Some Weed More Expensive Than Others? Understanding Cannabis Pricing
Giphy

Unraveling Cannabis Pricing: Factors Behind the Cost of Weed


Step inside a cannabis dispensary for the first time and the experience can be overwhelming. The meticulously labeled glass jars showcase dozens of strains with names like "Wedding Cake" and "Blue Dream," while refrigerated cases display concentrates, edibles, and tinctures at wildly different price points. Unlike the days when consumers were limited to whatever their neighborhood dealer offered, today's legal market presents a dazzling array of options that might leave newcomers with both wonder and sticker shock.

Keep ReadingShow less
Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Hall of Flowers NYC Debut: Cali Vibes Minus the Pulse of NY Cannabis

Photo courtesy of Hall of Flowers

Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Upon entering through the doors at Pier 36 it was refreshing to see row after row of identical booths, neat as a spreadsheet, designed to let the product speak for itself. Buyers drifted through the aisles with line sheets instead of selfie sticks, the volume dialed way down compared to last month's Revelry event at the same location. And, maybe that was the point. Hall of Flowers’ first New York edition was designed for commerce, not commotion: a buyers-only opening day, tight credentialing, a controlled environment and pace that favored real conversations over spectacle.

The uniformity of Hall of Flowers' format erased the booth-flex arms race; most of the brands stood shoulder-to-shoulder on product, pricing, and execution. “Much easier to have conversations here than at Revelry,” several attendees told us. Others called it “weak” or “quiet” by comparison. One marketing exec involved in the event went all in saying, “Revelry is a flea market compared to Hall of Flowers.” What he meant by that is: Hall of Flowers is a curated, high-end trade event, whereas Revelry functions more as a community marketplace. I could see his point.

Keep ReadingShow less
Lights, Camera, Cannabis: The New Theater Experience
Cigar smoking in a bar....
Giphy

NY Movie Theaters: High on Cannabis Lounges

In the dimly lit ambiance of New York City's historic movie theaters, the scent of buttered popcorn has long been the olfactory hallmark. However, as cannabis legalization sweeps across the state, a provocative question emerges: Could the future of cinema include the aroma of cannabis alongside the traditional concessions?

The Current Landscape of Cannabis Consumption Lounges

New York State’s Clean Indoor Air Act (CIAA) casts a long shadow over this budding idea. Enacted to safeguard public health, the CIAA prohibits smoking and vaping in most indoor workplaces, encompassing bars, restaurants, and, notably, movie theaters. The act defines smoking expansively, including the burning of tobacco, cannabis, or cannabinoid-hemp products. Violations can result in fines up to $2,000 for each infraction, underscoring the state’s commitment to maintaining smoke-free public spaces.

Keep ReadingShow less